Vitasora Health Limited · ASX:VHL
Vitasora Health — Investor Presentation (May 2024)
13 slides from Vitasora Health's investor presentation, May 9, 2024
Slide 1: Respiri Driving:
ASX: RSH OTCQB: RSHUF Respiri Driving: ➢Strategic New Client contracts & engagement ➢Accelerated Patient recruitment with existing clients Marjan Mikel (CEO) ➢New standards of patient care May 9th 2024 1 Approved by the Respiri Board
Slide 2: Forward looking
Forward looking Certain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts but rather are based on Respiri’s current expectations, estimates and projections about the industry in which Respiri operates, and its beliefs and a
Slide 3: Respiri a unique RPM Partner in the USA
Respiri a unique RPM Partner in the USA Aligned around 2 fundamental US customer revenue models Fee For Service Model Risk Share Model - New Revenue Channel - Current Revenue Channel - Funding US$20-US$80 pmpm/pppm - Customer Reimbursement payment - Growing funding/engagement model. driven - Per pat
Slide 4: Clinic in Cloud (CiC). Current Model Choke Points
Clinic in Cloud (CiC). Current Model Choke Points Requires client attention that is not day-to-day for them. Time & resource Patient Contract Choke Risk Patient Choke contacted Patient signed Point identified Point & onboarded consented Device RPM Choke CPT Escalation delivered, clinical Point reimb
Slide 5: Clinic in Cloud (CiC). Mitigates engagement choke points
Clinic in Cloud (CiC). Mitigates engagement choke points Greater control, easier for clients, better results, improved margins X X Patient Contract Choke Risk Patient Choke contacted Patient signed Point identified Point & onboarded consented X Device RPM Choke CPT Escalation delivered, clinical Poi
Slide 6: Significant commercial milestones ensuring revenue inflection & success in H2 CY2024
ASX: RSH OTCQB: RSHUF Significant commercial milestones ensuring revenue inflection & success in H2 CY2024 6 Approved by the Respiri Board
Slide 7: 1st: Hawaiian Independent Physicians Association (HIPA)
1st: Hawaiian Independent Physicians Association (HIPA) Quantifying RPM Outcomes driven cost-optimisation ~1,000 Physician ~450 PCP ~ 600,000+ Patients ~ 60 PCP ~41,000 patients Risk share Program Risk share Program 7
Slide 8: A significant commercial catalyst
A significant commercial catalyst Measuring our impact, our commercial worth - Measuring OUR impact on Health outcomes & ROI. 1st patient late 06/24 - Targeting patients in risk share Programs - Ground-breaking high risk/response patient profiling - Clinic in the Cloud (CiC) service - Accelerate pat
Slide 9: Wheezo: new standard of COPD RPM care with Queens Health System
Wheezo: new standard of COPD RPM care with Queens Health System. Hawaii’s biggest! - Largest Hospital/Integrated Healthcare Organisation. 8,000 healthcare providers & four major hospitals - Unique wheezo COPD program - RPM Transition Care Management. Admitted In-patient Hospital patients - RPM At Ho
Slide 10: Getting it right with Angelic Health.
Getting it right with Angelic Health. Expanding services into newly acquired primary care services - Palliative Care. “Risk” model $70 pppm - Targeted 150 patients pa. - 120 referred. 10/wk and growing - Acquired 6 primary care practices - 30,000+ patients - Requested RPM services expansion. - 1,500
Slide 11: Investment in becoming a leading fully integrated healthcare provider is paramount.
Investment in becoming a leading fully integrated healthcare provider is paramount. Becoming a leading end-to-end RPM provider and cash flow positive in late 2024. Respiri Yesterday Respiri Today An eHealth SAAS company A diversified RPM provider with an supporting respiratory health integrated solu
Slide 12: Everything is now in place for success & magnitude shift in Revenues
Everything is now in place for success & magnitude shift in Revenues Targeting Monthly cashflow break even in late 2024 - Unique revenue alignment Traditional and Risk Share. - Strategic clients engaged & impact to be quantified. - Clinic in Cloud mitigating choke points & improving margins - Gettin
Slide 13: Disclaimer statement
Disclaimer statement This report identifies some of the major risks associated with an investment in the Company. The risk factors below ought not to be taken as exhaustive of the risks faced by the Company or by investors in the Company. Speculative nature of investment: An investment in Shares of